regeneron-pharmaceuticals website screenshot

regeneron-pharmaceuticals

Regeneron Pharmaceuticals is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases in eye disease, cancer, inflammation, infectious disease, and rare diseases. The Regeneron Genetics Center (RGC) is a wholly owned subsidiary that has sequenced over 3 million human exomes and pioneered the use of large-scale genomics to discover and validate drug targets. Regeneron open-sources bioinformatics tools including regenie (whole genome regression), CLAMMS (CNV detection), and TCRAI (T-cell receptor analysis) through its GitHub organizations at github.com/rgcgithub and github.com/regeneron-mpds.

regeneron-pharmaceuticals is profiled on the APIs.io network. Tagged areas include Pharmaceuticals, Biotechnology, Genomics, Bioinformatics, and Drug Discovery.

The regeneron-pharmaceuticals catalog on APIs.io includes 1 JSON-LD context and 1 Spectral governance ruleset.

regeneron-pharmaceuticals’ developer surface includes GitHub presence and 6 more developer resources.

🌐 Visit website 📡 Source on GitHub
21.3/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
PharmaceuticalsBiotechnologyGenomicsBioinformaticsDrug DiscoveryClinical ResearchLife SciencesFortune 500

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 21.3/100 · emerging
Contract Quality 3.8 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.7 / 13
Governance 10.4 / 12
Discoverability 6.0 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/regeneron-pharmaceuticals: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Semantic Vocabularies 1

JSON-LD contexts and semantic vocabularies used across these APIs.

Regeneron Pharmaceuticals Context

27 classes · 3 properties

JSON-LD

Spectral Rules 1

Spectral governance rulesets for linting and validating these APIs.

regeneron-pharmaceuticals API Rules

5 rules · 3 warnings 2 info

SPECTRAL

JSON Schema 2

Standalone JSON Schema definitions for this provider's data models.

Drug Target

10 properties

JSON SCHEMA

Genomic Variant

14 properties

JSON SCHEMA

JSON Structure 2

JSON Structure definitions describing this provider's data shapes.

Regeneron Drug Target Structure

0 properties

JSON STRUCTURE

Regeneron Genomic Variant Structure

0 properties

JSON STRUCTURE

Examples 2

Example request and response payloads for these APIs.

Regeneron Drug Target Example

2 fields

EXAMPLE

Regeneron Genomic Variant Example

2 fields

EXAMPLE

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Regeneron Pharmaceuticals Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Press 5

Recent news and press coverage referencing this provider.

Teaching Machines to do New Tricks | Regeneron Stories

2026-05-25

TriNetX Collaborates with Regeneron to Access De- ...

2026-05-25

Regeneron Collaborates with TriNetX to Access De- ...

2026-05-25

Regeneron Doubles Down on Data with TriNetX ...

2026-05-25

Emerging AI - The Nucleus | Regeneron Stories

2026-05-25

Resources

Design & Contract 1

Pagination, idempotency, versioning, errors, and events

Vocabulary
Vocabulary

Build 2

SDKs, sample code, and the tooling you integrate with

GitHub
GitHub
 GitHub
GitHub

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 2

The organization behind the API

Website
Website
 LinkedIn
LinkedIn

Other 1

Properties that don't map to a standard resource type

Research
Research

Source (apis.yml)

apis.yml Raw ↑ 
aid: regeneron-pharmaceuticals
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/regeneron-pharmaceuticals.png
url: https://raw.githubusercontent.com/api-evangelist/regeneron-pharmaceuticals/refs/heads/main/apis.yml
modified: '2026-05-02'
description: Regeneron Pharmaceuticals is a leading biotechnology company that invents, develops, and commercializes life-transforming
  medicines for people with serious diseases in eye disease, cancer, inflammation, infectious disease, and rare diseases.
  The Regeneron Genetics Center (RGC) is a wholly owned subsidiary that has sequenced over 3 million human exomes and pioneered
  the use of large-scale genomics to discover and validate drug targets. Regeneron open-sources bioinformatics tools including
  regenie (whole genome regression), CLAMMS (CNV detection), and TCRAI (T-cell receptor analysis) through its GitHub organizations
  at github.com/rgcgithub and github.com/regeneron-mpds.
apis: []
common:
- type: DomainSecurity
  url: security/regeneron-pharmaceuticals-domain-security.yml
- type: Website
  url: https://www.regeneron.com
- type: Research
  url: https://www.regeneron.com/science/genetics-center
- type: GitHub
  url: https://github.com/rgcgithub
- type: GitHub
  url: https://github.com/regeneron-mpds
- type: LinkedIn
  url: https://www.linkedin.com/company/regeneron-pharmaceuticals
- type: Vocabulary
  url: https://raw.githubusercontent.com/api-evangelist/regeneron-pharmaceuticals/refs/heads/main/vocabulary/regeneron-pharmaceuticals-vocabulary.yml
tags:
- Pharmaceuticals
- Biotechnology
- Genomics
- Bioinformatics
- Drug Discovery
- Clinical Research
- Life Sciences
- Fortune 500